The World Health Organization identifies superbugs, including MRSA, as major public health threats, causing 1.27 million deaths annually due to antibiotic resistance.
Research reveals MRSA employs a dual defense mechanism against antimicrobials, complicating treatments and increasing the urgency for new antibiotic strategies.
Despite available treatments like linezolid and daptomycin, MRSA shows resistance, emphasizing the challenge in managing infections effectively.
Foster highlights MRSA's acquisition of the MecA gene, integral to cell wall formation, allowing the bacteria to resist beta-lactam antibiotics.
Collection
[
|
...
]